Trust Co. of Toledo NA OH Purchases 797 Shares of GSK PLC Sponsored ADR $GSK

Trust Co. of Toledo NA OH increased its position in GSK PLC Sponsored ADR (NYSE:GSK) by 2.7% during the second quarter, Holdings Channel reports. The firm owned 30,805 shares of the pharmaceutical company’s stock after buying an additional 797 shares during the quarter. Trust Co. of Toledo NA OH’s holdings in GSK were worth $1,183,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. HHM Wealth Advisors LLC raised its holdings in shares of GSK by 222.2% in the 1st quarter. HHM Wealth Advisors LLC now owns 667 shares of the pharmaceutical company’s stock valued at $26,000 after purchasing an additional 460 shares during the period. Costello Asset Management INC bought a new stake in shares of GSK in the 1st quarter valued at about $31,000. SOA Wealth Advisors LLC. raised its holdings in shares of GSK by 252.1% in the 2nd quarter. SOA Wealth Advisors LLC. now owns 845 shares of the pharmaceutical company’s stock valued at $32,000 after purchasing an additional 605 shares during the period. Richardson Financial Services Inc. raised its holdings in shares of GSK by 127.9% in the 1st quarter. Richardson Financial Services Inc. now owns 841 shares of the pharmaceutical company’s stock valued at $33,000 after purchasing an additional 472 shares during the period. Finally, Olde Wealth Management LLC bought a new stake in shares of GSK in the 1st quarter valued at about $36,000. 15.74% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on GSK shares. Weiss Ratings reissued a “hold (c)” rating on shares of GSK in a report on Wednesday. Wall Street Zen raised shares of GSK from a “buy” rating to a “strong-buy” rating in a report on Friday, September 5th. Seven research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $37.38.

GSK Stock Up 0.2%

GSK stock opened at $43.53 on Friday. The company’s 50-day moving average price is $40.33 and its two-hundred day moving average price is $38.85. GSK PLC Sponsored ADR has a twelve month low of $31.72 and a twelve month high of $45.59. The stock has a market cap of $88.55 billion, a P/E ratio of 20.15, a P/E/G ratio of 1.96 and a beta of 0.53. The company has a quick ratio of 0.57, a current ratio of 0.87 and a debt-to-equity ratio of 1.07.

GSK (NYSE:GSK) last announced its earnings results on Wednesday, July 30th. The pharmaceutical company reported $1.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.11. GSK had a net margin of 10.81% and a return on equity of 49.22%. The firm had revenue of $10.64 billion for the quarter, compared to analyst estimates of $7.92 billion. During the same quarter in the prior year, the business posted $0.43 EPS. The business’s revenue was up 1.3% compared to the same quarter last year. GSK has set its FY 2025 guidance at 4.590-4.590 EPS. As a group, analysts expect that GSK PLC Sponsored ADR will post 4.14 EPS for the current year.

GSK Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 9th. Shareholders of record on Friday, August 15th were given a dividend of $0.4206 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date was Friday, August 15th. GSK’s dividend payout ratio is presently 78.24%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.